VR1 provides the VR/AR software platform which it developed in house and is called FrameS. The platform is very flexible and their business model is to sell custom versions of the software to suit the customers requirements, and then charge an annual subscription fee which may range from say $2000-$5000 per licence. This is the recurring revenue part.
VR1 also charges one-off consulting fees to develop the customer solution, these can range from say $50k, to much more. For example, if VR1 is developing a whole suite of VR training modules to a client, the one-off fee may be in the hundreds of thousands.
In this instance, if the hospital trial is a success and adopted by tens or hundreds of other hospitals, VR1 will be paid for an annual fee by each, plus I would imagine ongoing development and customisation fees.
- Forums
- ASX - By Stock
- Ann: Vection Secures First Public Hospital Trial
VR1 provides the VR/AR software platform which it developed in...
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $13.26M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $68.65K | 6.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3149438 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 2447263 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 816105 | 0.009 |
20 | 4077791 | 0.008 |
18 | 5593533 | 0.007 |
8 | 1979832 | 0.006 |
2 | 500000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 2140988 | 4 |
0.011 | 2938062 | 7 |
0.012 | 4598539 | 8 |
0.015 | 366700 | 2 |
0.016 | 170000 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |